Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Schizophrenia: elevated cerebrospinal fluid norepinephrine

C R Lake, D E Sternberg, D P van Kammen

    Science (New York, N.Y.)
    |January 18, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Membrane polyunsaturated fatty acids and CSF cytokines in patients with schizophrenia.

    Prostaglandins, leukotrienes, and essential fatty acids·2003
    Same author

    Characterization of human cleaved N-CAM and association with schizophrenia.

    Experimental neurology·2001
    Same author

    Neuroleptic effects on autonomic activity in schizophrenia: between-group and within-subject paradigms and comparisons with controls.

    Schizophrenia bulletin·2001
    Same author

    Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications.

    CNS drugs·2001
    Same author

    Confirmation of a two-factor model of premorbid adjustment in males with schizophrenia.

    Schizophrenia bulletin·2001
    Same author

    Abnormal age-related changes of plasma antioxidant proteins in schizophrenia.

    Psychiatry research·2001
    Same journal

    Erratum for the Research Article "Detecting supramolecular organic nanoparticles during heat wave".

    Science (New York, N.Y.)·2026
    Same journal

    Local signals, systemic decline.

    Science (New York, N.Y.)·2026
    Same journal

    The mechanics of liver regeneration.

    Science (New York, N.Y.)·2026
    Same journal

    Computing in a memory with physics.

    Science (New York, N.Y.)·2026
    Same journal

    Retraction.

    Science (New York, N.Y.)·2026
    Same journal

    Making time.

    Science (New York, N.Y.)·2026
    See all related articles

    Cerebrospinal fluid norepinephrine levels are elevated in schizophrenic patients, especially those with paranoid schizophrenia. This suggests abnormal norepinephrine activity in the brain may contribute to schizophrenia symptoms.

    Area of Science:

    • Neuroscience
    • Psychiatry

    Background:

    • Schizophrenia is a complex mental disorder.
    • Norepinephrine is a key neurotransmitter implicated in various brain functions.

    Purpose of the Study:

    • To investigate cerebrospinal fluid (CSF) norepinephrine concentrations in patients with schizophrenia.
    • To compare these levels with those in healthy individuals.

    Main Methods:

    • Measurement of norepinephrine concentrations in the CSF of schizophrenic patients and age-matched normal volunteers.

    Main Results:

    • Significantly higher CSF norepinephrine levels were observed in schizophrenic patients compared to controls.
    • Elevated levels were particularly pronounced in patients with paranoid features.

    Related Experiment Videos

    Conclusions:

    • Increased norepinephrine in CSF may indicate heightened release or reduced breakdown in schizophrenic patients.
    • These findings support the role of norepinephrine dysregulation in the pathophysiology of schizophrenia, particularly paranoid subtypes.